Bristol-Myers (BMY) Shares Continuing Lower as Morgan Stanley Cuts to Equalweight

January 19, 2012 10:18 AM EST
Get Alerts BMY Hot Sheet
Price: $63.83 -1.27%

Rating Summary:
    12 Buy, 22 Hold, 4 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Shares of Bristol-Myers Squibb Co. (NYSE: BMY) are dipping rather sharply Thursday morning following a just-released downgrade from Morgan Stanley. The stock last traded at $33 even, down nearly 2.2 percent from Wednesday's close.

The firm now rates Bristol-Myers shares an Equalweight, down from Overweight previously.

For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Related Entities

Morgan Stanley